Search the Newsreel

MetaVia Inc. (MTVA) Holds Gains Near $1.49 as Biotech Stock Tests Key Resistance - ATR Stop

MetaVia Inc. (MTVA) Slides 4% to $1.43 as $1.36 Support Comes Under Pressure - IV Contraction

MetaVia Inc (MTVA) Earnings Forecast: Future EPS & Revenue Growth Estimates

MetaVia Inc (MTVA) has a price target of USD 15.50, with analysts forecasting a high of USD 21.00 and a low of USD 3.00. The company's EPS for the previous quarter was USD -0.79, exceeding the market expectation of USD -0.90, and the next …

MetaVia Inc. (NASDAQ: MTVA) Share Price, MTVA Stock News, MTVA Share Price & Updates

This page provides current stock information for MetaVia Inc. (NASDAQ: MTVA), including its stock price, daily range, and recent performance. It also lists several analyst recommendations and news updates related to the company's participation in investor forums and conferences. Financial data such as market …

MTVA: Q2 2026 saw clinical progress and a $5.3M net loss, with cash reserves at $12.6M

MTVA (MetaVia Inc.) reported significant clinical progress in Q2 2026 for its DA-1726 and vanoglipel programs, with Phase 1 data showing promising weight loss and liver outcomes. Despite a widened net loss of $5.3 million due to increased R&D, the company's cash reserves grew …

MetaVia Inc. Q2 2026: Net loss $5.3M, EPS $(0.90) — 10-Q Summary

MetaVia Inc. reported a net loss of $5.3 million for Q2 2026, with a diluted loss per share of $(0.90), showing an increase in net loss compared to the previous year but an improved EPS. The company also highlighted progress in its clinical pipeline, …

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Inc. announced its Q2 2026 financial results, highlighting progress in its clinical development programs for DA-1726 and vanoglipel. The company successfully reached the highest planned dose levels in its Phase 1 Part 3 study of DA-1726 for obesity, with 16-week topline data expected …

MetaVia Inc. (MTVA) Holds Steady at $1.46 as Shares Consolidate Between Key Levels - Insider Buying Alerts

MetaVia Inc. (MTVA) Slips to $1.40 as Support Holds at $1.33 - Bullish Percent Index

Form S-1 MetaVia Inc For: 29 July By Investing.com

This article announces the filing of Form S-1 by MetaVia Inc. on July 29. The brief report highlights this corporate action, possibly relating to an initial public offering or a new securities registration. The article provides only this essential information and is presented by …

MTVA Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue Development Stage - Earnings Power Value

MetaVia Inc (MTVA) Income Statement

This article provides the quarterly and annual income statements for MetaVia Inc (MTVA), detailing financial performance metrics such as operating expenses, R&D, depreciation, operating profit, and net income over several fiscal years and quarters. It also includes frequently asked questions about understanding the income …

MetaVia Inc (MTVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for MetaVia Inc (MTVA), detailing that relevant data for business segments and regional contributions have not yet been disclosed by the company. It briefly shows MetaVia's current stock price, market cap, and links to its financials, …

MetaVia Inc (MTVA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of MetaVia Inc (MTVA)'s dividend and stock split history. It notes that no dividends have been distributed in the past five years. The article details several stock merger events with 8:1 and 30:1 ratios that occurred in August 2023 …

MetaVia Inc (MTVA) Institutional Confidence

This article provides details on the institutional confidence in MetaVia Inc (MTVA), listing key shareholders and their recent activity. Notable shareholders include Dong-A ST Co., Ltd., Citadel Advisors LLC, and individual investors like Kim (Hyung Heon) and Woodworth (Marshall H), with several showing significant …

MetaVia Inc (MTVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of MetaVia Inc (MTVA), detailing its support, resistance levels, and various technical indicators. It presents the stock's current market data, including its closing price and market cap, and evaluates its technical health through indicators like MACD, RSI, and …

MetaVia Inc. (MTVA) Slips 1.99% as Shares Trade Near Key Support Levels - Percent Below MA

MetaVia Inc (MTVA) Valuation: PE, PB & Fair Value Analysis

This article provides a brief valuation analysis for MetaVia Inc (MTVA), noting its current stock price and market capitalization. It highlights that key valuation metrics such as P/E, P/B, and P/CF ratios are currently undisclosed by the company. The article is part of TradingKey's …

MTVA Cash Flow Statement

This article provides the quarterly and annual cash flow statements for MetaVia Inc (MTVA), presenting detailed financial data related to operating, investing, and financing activities. It includes historical cash flow figures, year-over-year changes, and definitions for key cash flow metrics such as operating cash …

MTVA|MetaVia Inc|Price:1.430|Chg%:-0.060

This article provides a detailed financial summary for MetaVia Inc (MTVA), including its current stock price, market capitalization, and upcoming earnings date. It presents a comprehensive overview of the company's income statement, balance sheet, and cash flow statement, highlighting key financial indicators and year-over-year …

MTVA|MetaVia Inc|Price:1.480|Chg%:-0.030

This article provides a detailed financial summary for MetaVia Inc (MTVA), including its current stock price, market capitalization, and upcoming earnings date. It presents a comprehensive overview of the company's income statement, balance sheet, and cash flow statement, highlighting key financial indicators and year-over-year …

MetaVia Inc. Revenue Breakdown – NASDAQ:MTVA

This article provides a revenue breakdown for MetaVia Inc. (NASDAQ: MTVA) as part of its financial overview on TradingView. It indicates that further details on top segments and regional performance are available by source and country. The information is presented within the context of …

MetaVia completes dose titration in obesity drug trial By Investing.com

MetaVia Inc. announced that all patients in Part 3 of its Phase 1 clinical trial for the obesity treatment candidate DA-1726 have completed dose titration, reaching target doses of 48 mg and 64 mg. The trial evaluates the safety, tolerability, pharmacokinetics, and pharmacodynamics of …